9.14MMarket Cap-1.72P/E (TTM)
0.441High0.411Low30.94KVolume0.411Open0.441Pre Close13.31KTurnover0.33%Turnover RatioLossP/E (Static)21.26MShares13.10052wk High6.23P/B4.00MFloat Cap0.26052wk Low--Dividend TTM9.30MShs Float13.100Historical High--Div YieldTTM6.89%Amplitude0.260Historical Low0.430Avg Price1Lot Size
Klotho Neurosciences Stock Forum
Former Merck USA President Joins Klotho Neurosciences' Board of Directors
Tuesday, 3rd December at 11:00 am
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related disorders, including ALS, Alzheimer's, and Parkinson's, today announced the appointment of Riad El-Dada, former US President of Merck, to its Board of Dire...
No comment yet